Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Samson

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|January 1, 1983
Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic studyC Karanes, J D Young, M K Samson, et al.
Cancer Treatment Reports|January 1, 1976
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875)M K Samson, L H Baker, J M Devos, et al.
Surgery, Gynecology & Obstetrics|August 1, 1975
Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapyM D Henderson, T R Buroker, M K Samson, et al.
European Journal of Cancer|March 1, 1981
Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancerR W Talley, M K Samson, R W Brownlee, et al.
Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.
Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group StudyA H Rossof, R W Talley, R Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.
Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.
Cancer Treatment Reports|May 1, 1982
Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapyJ E White, T Chen, R Reed, et al.
Cancer|March 1, 1984
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group studyM K Samson, S E Rivkin, S E Jones, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|January 1, 1983
Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic studyC Karanes, J D Young, M K Samson, et al.
Cancer Treatment Reports|January 1, 1976
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875)M K Samson, L H Baker, J M Devos, et al.
Surgery, Gynecology & Obstetrics|August 1, 1975
Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapyM D Henderson, T R Buroker, M K Samson, et al.
European Journal of Cancer|March 1, 1981
Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancerR W Talley, M K Samson, R W Brownlee, et al.
Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.
Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group StudyA H Rossof, R W Talley, R Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.
Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.
Cancer Treatment Reports|May 1, 1982
Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapyJ E White, T Chen, R Reed, et al.
Cancer|March 1, 1984
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group studyM K Samson, S E Rivkin, S E Jones, et al.
Pageof 6